![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, December 22, 2020 5:27:42 AM
This vaccine took 9 months to get through clinical trials to approvals.
Yes, that's fast, but not crazy when you consider:
1) They had lots of test subjects. Recruiting 1000s of volunteers for phase 1, 2 and 3 clinical trials was easy and quick, compared to most vaccines which take a long time to get enough people enrolled in trials.
2) Lots of government funding support for the trials
3) FDA bumps to the front of the line for review.
So, yes, it was fast, but not due to cutting corners on collecting data.
You're kind of right about the long-term health effects data. That's why it's emergency use authorization. Still, they have some data in the 4 to 5 month timeframe, and so far, so good.
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM